How many patents does
Roche have?
patents
53,364
families
5,696
granted
11,203
applications
42,161
US
8,665
EP
6,976
CN
4,819
WO
4,184
JP
2,980
KR
2,223
GB
4
RoW
23,513
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Roche
Top ten assignees appearing on patents
2009 - 2018
| roche | 36129 |
| roche diagnostics | 5182 |
| genentech | 4435 |
| roche diagnostics operations | 2160 |
| roche diabetes care | 938 |
| ventana medical systems | 839 |
| roche molecular systems | 795 |
| roche glycart | 317 |
| roche palo alto | 305 |
| siena biotech | 215 |
2009
| roche | 3811 |
| roche diagnostics | 585 |
| roche diagnostics operations | 93 |
| genentech | 69 |
| roche palo alto | 62 |
| arius research | 33 |
| roche molecular systems | 31 |
| medingo | 27 |
| isotechnika | 20 |
| glycart biotechnology | 16 |
2018
| roche | 2873 |
| genentech | 573 |
| roche diabetes care | 363 |
| roche diagnostics | 342 |
| roche diagnostics operations | 197 |
| ventana medical systems | 155 |
| roche molecular systems | 131 |
| roche sequencing solutions | 66 |
| genia technologies | 25 |
| roche glycart | 25 |
Roche
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| method to identify a patient with an increased likelihood of responding to an anti-cance… 🛈 | 109 | 2010 |
| pyrrolopyrazine kinase inhibitors | 79 | 2008 |
| anti-pd-l1 antibodies and their use to enhance t-cell function | 77 | 2008 |
| antibodies against human angiopoietin 2 | 75 | 2008 |
| pyridin- 2 -amides useful as cb2 agonists | 69 | 2011 |
| subcutaneous anti-her2 antibody formulation | 66 | 2009 |
| benzoxazepin pi3k inhibitor compounds and methods of use | 65 | 2009 |
| highly concentrated pharmaceutical formulations | 64 | 2009 |
| novel cyclosporin analog microemulsion preconcentrates | 63 | 2001 |
| antibodies binding preferentially human csf1r extracellular domain 4 and their use | 62 | 2009 |